Clinical trial
Bisoprolol Versus Cognitive Behavioral Therapy on Cortisol, Blood Pressure, and Anxiety in Patients on Continuous Ambulatory Peritoneal Dialysis: A Pilot Quasi-Experimental Study
NCT07899281 is registered in ClinicalTrials.gov with Universitas Sebelas Maret as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bisoprolol Versus Cognitive Behavioral Therapy on Cortisol, Blood Pressure, and Anxiety in Patients on Continuous Ambulatory Peritoneal Dialysis: A Pilot Quasi-Experimental Study
- Lead sponsor
- Universitas Sebelas Maret
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 10, 2022
- Completion date
- March 9, 2023
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anxiety, kidney failure, chronic, peritoneal dialysis, continuous ambulatory, psychological stress
Arms
As registered; 2 arms.
-
Cognitive behavioral therapy
Individual cognitive behavioral therapy for 30 days, given during routine clinic visits, in addition to usual care.
-
Bisoprolol
Oral bisoprolol 5 mg once daily for 30 days, in addition to usual care.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Change in morning blood cortisol
Blood cortisol (microgram/dL) measured from a morning venous blood sample. Change = day-30 value minus baseline value.
Lead sponsor's other trials
Universitas Sebelas Maret, most recent start first.
+24 more trials
Similar trials
Same condition (Kidney Failure, Chronic) and phase, most recent start first.
+230 more trials See the condition page